Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [18F]Fallypride
Identifieur interne : 000771 ( PascalFrancis/Corpus ); précédent : 000770; suivant : 000772Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [18F]Fallypride
Auteurs : Marta G. Vuckovic ; QUANZHENG LI ; Beth Fisher ; Angelo Nacca ; Richard M. Leahy ; John P. Walsh ; Jogesh Mukherjee ; Celia Williams ; Michael W. Jakowec ; Giselle M. PetzingerSource :
- Movement disorders [ 0885-3185 ] ; 2010.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
The purpose of the current study was to examine changes in dopamine D2 receptor (DA-D2R) expression within the basal ganglia of MPTP mice subjected to intensive treadmill exercise. Using Western immunoblotting analysis of synaptoneurosomes and in vivo positron emission tomography (PET) imaging employing the DA-D2R specific ligand [18F]fallypride, we found that high intensity treadmill exercise led to an increase in striatal DA-D2R expression that was most pronounced in MPTP compared to saline treated mice. Exercise-induced changes in the DA-D2R in the dopamine-depleted basal ganglia are consistent with the potential role of this receptor in modulating medium spiny neurons (MSNs) function and behavioral recovery. Importantly, findings from this study support the rationale for using PET imaging with [18F]fallypride to examine DA-D2R changes in individuals with Parkinson's Disease (PD) undergoing high-intensity treadmill training.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 11-0065128 INIST |
---|---|
ET : | Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [18F]Fallypride |
AU : | VUCKOVIC (Marta G.); QUANZHENG LI; FISHER (Beth); NACCA (Angelo); LEAHY (Richard M.); WALSH (John P.); MUKHERJEE (Jogesh); WILLIAMS (Celia); JAKOWEC (Michael W.); PETZINGER (Giselle M.) |
AF : | Neuroscience Graduate Program, University of Southern California/Los Angeles, California/Etats-Unis (1 aut.); The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California/Los Angles, California/Etats-Unis (1 aut., 8 aut., 9 aut., 10 aut.); Viterbi School of Engineering, University of Southern California/Los Angeles, California/Etats-Unis (2 aut., 5 aut.); Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California/Los Angeles, California/Etats-Unis (3 aut., 9 aut., 10 aut.); Department of Radiology, University of Southern California/Los Angeles, California/Etats-Unis (4 aut.); Andrus Gerontology Center, University of Southern California/Los Angeles, California/Etats-Unis (6 aut.); Preclinical Imaging Center, Department of Psychiatry and Human Behavior, UC Irvine/Irvine, California/Etats-Unis (7 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 16; Pp. 2777-2784; Bibl. 36 ref. |
LA : | Anglais |
EA : | The purpose of the current study was to examine changes in dopamine D2 receptor (DA-D2R) expression within the basal ganglia of MPTP mice subjected to intensive treadmill exercise. Using Western immunoblotting analysis of synaptoneurosomes and in vivo positron emission tomography (PET) imaging employing the DA-D2R specific ligand [18F]fallypride, we found that high intensity treadmill exercise led to an increase in striatal DA-D2R expression that was most pronounced in MPTP compared to saline treated mice. Exercise-induced changes in the DA-D2R in the dopamine-depleted basal ganglia are consistent with the potential role of this receptor in modulating medium spiny neurons (MSNs) function and behavioral recovery. Importantly, findings from this study support the rationale for using PET imaging with [18F]fallypride to examine DA-D2R changes in individuals with Parkinson's Disease (PD) undergoing high-intensity treadmill training. |
CC : | 002B17; 002B17G |
FD : | Maladie de Parkinson; Pathologie du système nerveux; Exercice physique; Récepteur dopaminergique D2; Modèle animal; Tomoscintigraphie; Tomographie par émission de positons; Noyau gris central; Epreuve tapis roulant |
FG : | Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Encéphale; Système nerveux central |
ED : | Parkinson disease; Nervous system diseases; Physical exercise; D2 Dopamine receptor; Animal model; Emission tomography; Positron emission tomography; Basal ganglion; Treadmill exercise |
EG : | Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Encephalon; Central nervous system |
SD : | Parkinson enfermedad; Sistema nervioso patología; Ejercicio físico; Receptor dopaminérgico D2; Modelo animal; Tomocentelleografía; Tomografía emisión positrones; Núcleo basal; Prueba cinta rodante |
LO : | INIST-20953.354000193512620120 |
ID : | 11-0065128 |
Links to Exploration step
Pascal:11-0065128Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [<sup>18</sup>
F]Fallypride</title>
<author><name sortKey="Vuckovic, Marta G" sort="Vuckovic, Marta G" uniqKey="Vuckovic M" first="Marta G." last="Vuckovic">Marta G. Vuckovic</name>
<affiliation><inist:fA14 i1="01"><s1>Neuroscience Graduate Program, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Quanzheng Li" sort="Quanzheng Li" uniqKey="Quanzheng Li" last="Quanzheng Li">QUANZHENG LI</name>
<affiliation><inist:fA14 i1="03"><s1>Viterbi School of Engineering, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fisher, Beth" sort="Fisher, Beth" uniqKey="Fisher B" first="Beth" last="Fisher">Beth Fisher</name>
<affiliation><inist:fA14 i1="04"><s1>Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nacca, Angelo" sort="Nacca, Angelo" uniqKey="Nacca A" first="Angelo" last="Nacca">Angelo Nacca</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Radiology, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Leahy, Richard M" sort="Leahy, Richard M" uniqKey="Leahy R" first="Richard M." last="Leahy">Richard M. Leahy</name>
<affiliation><inist:fA14 i1="03"><s1>Viterbi School of Engineering, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Walsh, John P" sort="Walsh, John P" uniqKey="Walsh J" first="John P." last="Walsh">John P. Walsh</name>
<affiliation><inist:fA14 i1="06"><s1>Andrus Gerontology Center, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mukherjee, Jogesh" sort="Mukherjee, Jogesh" uniqKey="Mukherjee J" first="Jogesh" last="Mukherjee">Jogesh Mukherjee</name>
<affiliation><inist:fA14 i1="07"><s1>Preclinical Imaging Center, Department of Psychiatry and Human Behavior, UC Irvine</s1>
<s2>Irvine, California</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Williams, Celia" sort="Williams, Celia" uniqKey="Williams C" first="Celia" last="Williams">Celia Williams</name>
<affiliation><inist:fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jakowec, Michael W" sort="Jakowec, Michael W" uniqKey="Jakowec M" first="Michael W." last="Jakowec">Michael W. Jakowec</name>
<affiliation><inist:fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Petzinger, Giselle M" sort="Petzinger, Giselle M" uniqKey="Petzinger G" first="Giselle M." last="Petzinger">Giselle M. Petzinger</name>
<affiliation><inist:fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0065128</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 11-0065128 INIST</idno>
<idno type="RBID">Pascal:11-0065128</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000771</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [<sup>18</sup>
F]Fallypride</title>
<author><name sortKey="Vuckovic, Marta G" sort="Vuckovic, Marta G" uniqKey="Vuckovic M" first="Marta G." last="Vuckovic">Marta G. Vuckovic</name>
<affiliation><inist:fA14 i1="01"><s1>Neuroscience Graduate Program, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Quanzheng Li" sort="Quanzheng Li" uniqKey="Quanzheng Li" last="Quanzheng Li">QUANZHENG LI</name>
<affiliation><inist:fA14 i1="03"><s1>Viterbi School of Engineering, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fisher, Beth" sort="Fisher, Beth" uniqKey="Fisher B" first="Beth" last="Fisher">Beth Fisher</name>
<affiliation><inist:fA14 i1="04"><s1>Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Nacca, Angelo" sort="Nacca, Angelo" uniqKey="Nacca A" first="Angelo" last="Nacca">Angelo Nacca</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Radiology, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Leahy, Richard M" sort="Leahy, Richard M" uniqKey="Leahy R" first="Richard M." last="Leahy">Richard M. Leahy</name>
<affiliation><inist:fA14 i1="03"><s1>Viterbi School of Engineering, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Walsh, John P" sort="Walsh, John P" uniqKey="Walsh J" first="John P." last="Walsh">John P. Walsh</name>
<affiliation><inist:fA14 i1="06"><s1>Andrus Gerontology Center, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mukherjee, Jogesh" sort="Mukherjee, Jogesh" uniqKey="Mukherjee J" first="Jogesh" last="Mukherjee">Jogesh Mukherjee</name>
<affiliation><inist:fA14 i1="07"><s1>Preclinical Imaging Center, Department of Psychiatry and Human Behavior, UC Irvine</s1>
<s2>Irvine, California</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Williams, Celia" sort="Williams, Celia" uniqKey="Williams C" first="Celia" last="Williams">Celia Williams</name>
<affiliation><inist:fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jakowec, Michael W" sort="Jakowec, Michael W" uniqKey="Jakowec M" first="Michael W." last="Jakowec">Michael W. Jakowec</name>
<affiliation><inist:fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Petzinger, Giselle M" sort="Petzinger, Giselle M" uniqKey="Petzinger G" first="Giselle M." last="Petzinger">Giselle M. Petzinger</name>
<affiliation><inist:fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal model</term>
<term>Basal ganglion</term>
<term>D2 Dopamine receptor</term>
<term>Emission tomography</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Physical exercise</term>
<term>Positron emission tomography</term>
<term>Treadmill exercise</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Exercice physique</term>
<term>Récepteur dopaminergique D2</term>
<term>Modèle animal</term>
<term>Tomoscintigraphie</term>
<term>Tomographie par émission de positons</term>
<term>Noyau gris central</term>
<term>Epreuve tapis roulant</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The purpose of the current study was to examine changes in dopamine D2 receptor (DA-D2R) expression within the basal ganglia of MPTP mice subjected to intensive treadmill exercise. Using Western immunoblotting analysis of synaptoneurosomes and in vivo positron emission tomography (PET) imaging employing the DA-D2R specific ligand [<sup>18</sup>
F]fallypride, we found that high intensity treadmill exercise led to an increase in striatal DA-D2R expression that was most pronounced in MPTP compared to saline treated mice. Exercise-induced changes in the DA-D2R in the dopamine-depleted basal ganglia are consistent with the potential role of this receptor in modulating medium spiny neurons (MSNs) function and behavioral recovery. Importantly, findings from this study support the rationale for using PET imaging with [<sup>18</sup>
F]fallypride to examine DA-D2R changes in individuals with Parkinson's Disease (PD) undergoing high-intensity treadmill training.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>25</s2>
</fA05>
<fA06><s2>16</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [<sup>18</sup>
F]Fallypride</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>VUCKOVIC (Marta G.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>QUANZHENG LI</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>FISHER (Beth)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>NACCA (Angelo)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>LEAHY (Richard M.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>WALSH (John P.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>MUKHERJEE (Jogesh)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>WILLIAMS (Celia)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>JAKOWEC (Michael W.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>PETZINGER (Giselle M.)</s1>
</fA11>
<fA14 i1="01"><s1>Neuroscience Graduate Program, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California</s1>
<s2>Los Angles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Viterbi School of Engineering, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Radiology, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Andrus Gerontology Center, University of Southern California</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Preclinical Imaging Center, Department of Psychiatry and Human Behavior, UC Irvine</s1>
<s2>Irvine, California</s2>
<s3>USA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>2777-2784</s1>
</fA20>
<fA21><s1>2010</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000193512620120</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>36 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>11-0065128</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The purpose of the current study was to examine changes in dopamine D2 receptor (DA-D2R) expression within the basal ganglia of MPTP mice subjected to intensive treadmill exercise. Using Western immunoblotting analysis of synaptoneurosomes and in vivo positron emission tomography (PET) imaging employing the DA-D2R specific ligand [<sup>18</sup>
F]fallypride, we found that high intensity treadmill exercise led to an increase in striatal DA-D2R expression that was most pronounced in MPTP compared to saline treated mice. Exercise-induced changes in the DA-D2R in the dopamine-depleted basal ganglia are consistent with the potential role of this receptor in modulating medium spiny neurons (MSNs) function and behavioral recovery. Importantly, findings from this study support the rationale for using PET imaging with [<sup>18</sup>
F]fallypride to examine DA-D2R changes in individuals with Parkinson's Disease (PD) undergoing high-intensity treadmill training.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Exercice physique</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Physical exercise</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Ejercicio físico</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Récepteur dopaminergique D2</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>D2 Dopamine receptor</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Receptor dopaminérgico D2</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Modèle animal</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Animal model</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Modelo animal</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Tomoscintigraphie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Emission tomography</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tomocentelleografía</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Tomographie par émission de positons</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Positron emission tomography</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Tomografía emisión positrones</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Noyau gris central</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Basal ganglion</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Núcleo basal</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Epreuve tapis roulant</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Treadmill exercise</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Prueba cinta rodante</s0>
<s5>15</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Encéphale</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Encephalon</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Système nerveux central</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervioso central</s0>
<s5>43</s5>
</fC07>
<fN21><s1>045</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 11-0065128 INIST</NO>
<ET>Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [<sup>18</sup>
F]Fallypride</ET>
<AU>VUCKOVIC (Marta G.); QUANZHENG LI; FISHER (Beth); NACCA (Angelo); LEAHY (Richard M.); WALSH (John P.); MUKHERJEE (Jogesh); WILLIAMS (Celia); JAKOWEC (Michael W.); PETZINGER (Giselle M.)</AU>
<AF>Neuroscience Graduate Program, University of Southern California/Los Angeles, California/Etats-Unis (1 aut.); The George and Mary Lou Boone Center for Parkinson's Disease Research, Department of Neurology; University of Southern California/Los Angles, California/Etats-Unis (1 aut., 8 aut., 9 aut., 10 aut.); Viterbi School of Engineering, University of Southern California/Los Angeles, California/Etats-Unis (2 aut., 5 aut.); Philips-Fisher Center for Brain Repair and Rehabilitation, Division of Biokinesiology and Physical Therapy, University of Southern California/Los Angeles, California/Etats-Unis (3 aut., 9 aut., 10 aut.); Department of Radiology, University of Southern California/Los Angeles, California/Etats-Unis (4 aut.); Andrus Gerontology Center, University of Southern California/Los Angeles, California/Etats-Unis (6 aut.); Preclinical Imaging Center, Department of Psychiatry and Human Behavior, UC Irvine/Irvine, California/Etats-Unis (7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2010; Vol. 25; No. 16; Pp. 2777-2784; Bibl. 36 ref.</SO>
<LA>Anglais</LA>
<EA>The purpose of the current study was to examine changes in dopamine D2 receptor (DA-D2R) expression within the basal ganglia of MPTP mice subjected to intensive treadmill exercise. Using Western immunoblotting analysis of synaptoneurosomes and in vivo positron emission tomography (PET) imaging employing the DA-D2R specific ligand [<sup>18</sup>
F]fallypride, we found that high intensity treadmill exercise led to an increase in striatal DA-D2R expression that was most pronounced in MPTP compared to saline treated mice. Exercise-induced changes in the DA-D2R in the dopamine-depleted basal ganglia are consistent with the potential role of this receptor in modulating medium spiny neurons (MSNs) function and behavioral recovery. Importantly, findings from this study support the rationale for using PET imaging with [<sup>18</sup>
F]fallypride to examine DA-D2R changes in individuals with Parkinson's Disease (PD) undergoing high-intensity treadmill training.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Pathologie du système nerveux; Exercice physique; Récepteur dopaminergique D2; Modèle animal; Tomoscintigraphie; Tomographie par émission de positons; Noyau gris central; Epreuve tapis roulant</FD>
<FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Encéphale; Système nerveux central</FG>
<ED>Parkinson disease; Nervous system diseases; Physical exercise; D2 Dopamine receptor; Animal model; Emission tomography; Positron emission tomography; Basal ganglion; Treadmill exercise</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Encephalon; Central nervous system</EG>
<SD>Parkinson enfermedad; Sistema nervioso patología; Ejercicio físico; Receptor dopaminérgico D2; Modelo animal; Tomocentelleografía; Tomografía emisión positrones; Núcleo basal; Prueba cinta rodante</SD>
<LO>INIST-20953.354000193512620120</LO>
<ID>11-0065128</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000771 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000771 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:11-0065128 |texte= Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [18F]Fallypride }}
This area was generated with Dilib version V0.6.23. |